Dr Srinivas Akkaraju

Srinivas Akkaraju is a former General Partner of Sofinnova Ventures. Prior to Sofinnova, Srini was a Managing Director of New Leaf Venture Partners, and prior to that, a Founding Managing Director at Panorama Capital, LLC., a prior to that, a Partner with J.P. Morgan Partners.

Before his investment career, he was in Business and Corporate Development at Genentech, Inc. (now a wholly owned member of The Roche Group), a biotechnology company, most recently as Senior Manager. Dr Akkaraju currently serves as a Director of Intercept Pharmaceuticals, Inc., Seattle Genetics, Versartis Inc., and aTyr Pharma, Inc. Previously, Dr. Akkaraju served as a director on the boards of ZS Pharma, Inc., Eyetech Pharmaceuticals, Inc., Synageva Biopharma Corp., Barrier Therapeutics, Inc., and Amarin Corporation plc. Srinivas joined the Board February 2016.